Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFMW) Depreciation & Amortization (IS) (2016 - 2024)

Historic Depreciation & Amortization (IS) for Sunshine Biopharma (SBFMW) over the last 7 years, with Q1 2024 value amounting to $42618.0.

  • Sunshine Biopharma's Depreciation & Amortization (IS) rose 2278.31% to $42618.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $83911.0, marking a year-over-year increase of 8768.68%. This contributed to the annual value of $223527.0 for FY2024, which is 4987.03% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Depreciation & Amortization (IS) of $42618.0 as of Q1 2024, which was up 2278.31% from $34710.0 recorded in Q1 2023.
  • Over the past 5 years, Sunshine Biopharma's Depreciation & Amortization (IS) peaked at $42618.0 during Q1 2024, and registered a low of $3110.0 during Q1 2022.
  • For the 3-year period, Sunshine Biopharma's Depreciation & Amortization (IS) averaged around $26812.7, with its median value being $34710.0 (2023).
  • In the last 5 years, Sunshine Biopharma's Depreciation & Amortization (IS) skyrocketed by 101607.72% in 2023 and then soared by 2278.31% in 2024.
  • Over the past 3 years, Sunshine Biopharma's Depreciation & Amortization (IS) (Quarter) stood at $3110.0 in 2022, then skyrocketed by 1016.08% to $34710.0 in 2023, then rose by 22.78% to $42618.0 in 2024.
  • Its last three reported values are $42618.0 in Q1 2024, $34710.0 for Q1 2023, and $3110.0 during Q1 2022.